Fioricet and Naltrexone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Fioricet (acetaminophen; butalbital; caffeine) and Naltrexone (naltrexone). Common drug interactions include infusion related reaction among females and cognitive disorder among males.

The phase IV clinical study analyzes what interactions people have when they take Fioricet and Naltrexone. It is created by eHealthMe based on reports of 30 people who take the same drugs from the FDA, and is updated regularly.

What is Fioricet?

Fioricet has active ingredients of acetaminophen; butalbital; caffeine. It is often used in migraine. eHealthMe is studying from 12,423 Fioricet users. Check the latest studies of Fioricet.

What is Naltrexone?

Naltrexone has active ingredients of naltrexone. eHealthMe is studying from 4,835 Naltrexone users. Check the latest studies of Naltrexone.



On Aug, 05, 2026

30 people who take Fioricet and Naltrexone together, and have interactions are studied.

Fioricet and Naltrexone drug interactions.

What are the common drug interactions of Fioricet and Naltrexone, by gender? *:

female:

  1. Infusion related reaction
  2. Fall
  3. Drug ineffective
  4. Pyelonephritis (inflammation of kidney caused by bacteria)
  5. Urinary tract infection
  6. Anxiety
  7. Balance disorder
  8. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
  9. Drug hypersensitivity
  10. Gait disturbance

male:

  1. Cognitive disorder (mental health disorders affects learning, memory, perception, and problem solving)
  2. Tick-borne fever (fever due to tick bite infection)
  3. Circadian rhythm sleep disorder (family of sleep disorders affecting, among other things, the timing of sleep)
  4. Movement disorder (neurological syndromes where they may be excess of movement or a paucity of movement that is not connected to weakness)
  5. Encephalopathy (functioning of the brain is affected by some agent or condition)
  6. Hypersomnia (excessive daytime sleepiness (eds))
  7. Bacterial infection

What are the common drug interactions of Fioricet and Naltrexone, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Bacterial infection

20-29:

n/a

30-39:

  1. Abortion spontaneous (naturally occurring miscarriage)
  2. Anxiety
  3. Crohn's disease (a condition that causes inflammation of the gastrointestinal tract)
  4. Diarrhoea
  5. Drug ineffective
  6. Fatigue (feeling of tiredness)
  7. Hypersensitivity
  8. Hypertension (high blood pressure)
  9. Lymphadenopathy (disease or enlargement of lymph nodes)
  10. Nasopharyngitis (inflammation of the nasopharynx)

40-49:

  1. Adverse reaction
  2. Muscle spasms (muscle contraction)

50-59:

  1. Asthenia (weakness)
  2. Balance disorder
  3. Hypoaesthesia (reduced sense of touch or sensation)
  4. Hypotension (abnormally low blood pressure)
  5. Influenza like illness
  6. Multiple sclerosis relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath)
  7. Muscular weakness (muscle weakness)
  8. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  9. Pleurisy (inflammation of the pleurae, which causes pain when breathing)
  10. Rhinorrhoea (watery mucus discharge from the nose)

60+:

n/a

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 10 people, 33.33%
  2. Immunodeficiency Common Variable: 5 people, 16.67%
  3. Drowsiness: 4 people, 13.33%
  4. Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 6.67%
  5. Irritable Bowel Syndrome: 2 people, 6.67%
  6. Inflammatory Bowel Disease: 2 people, 6.67%
  7. Headache (pain in head): 2 people, 6.67%
  8. Bipolar Disorder (mood disorder): 2 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Fioricet and Naltrexone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Fioricet and Naltrexone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Fioricet:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Naltrexone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Fioricet and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Naltrexone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on acetaminophen; butalbital; caffeine and naltrexone (the active ingredients of Fioricet and Naltrexone, respectively), and Fioricet and Naltrexone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: